Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice-Reference-Cited by-同舟云学术

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

Published:2014-09-30 Issue:18 Volume:5 Page:8235-8251
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dupouy Sandra¹,Doan Van Kien¹,Wu Zherui¹²,Mourra Najat¹³,Liu Jin²,De Wever Olivier⁴,Llorca Frédérique Penault⁵,Cayre Anne⁵,Kouchkar Amal⁶,Gompel Anne²⁷,Forgez Patricia²

Affiliation:

1. UMRS U938, Hôpital Saint-Antoine, Paris, France

2. UMRS 1007 Université Paris Descartes 45, Paris, France

3. Pathology Department Hôpital Saint-Antoine, Paris, France

4. The Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium

5. Pathology Department, Jean Perrin Center, Clermont Ferrand, France

6. Pathology Department, Alger Pierre and Marie Curie Center, Algeria

7. Gynecology Unit, Université Paris Descartes, APHP, Hôpitaux Universitaires Cochin Hôtel-Dieu Broca, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NTSR1 glycosylation and MMP dependent cleavage generate three distinct forms of the protein;Scientific Reports;2023-03-22

2. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3;Peptides;2022-10

3. Supply chain logistics – the role of the Golgi complex in extracellular matrix production and maintenance;Journal of Cell Science;2022-01-01

4. The Neurotensinergic System: A Target for Cancer Treatment;Current Medicinal Chemistry;2021-10-27

5. Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors;Breast Cancer Research and Treatment;2021-10-01